Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

505 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gastrin increases murine intestinal crypt regeneration following injury.
Ottewell PD, Duckworth CA, Varro A, Dimaline R, Wang TC, Watson AJ, Dockray GJ, Pritchard DM. Ottewell PD, et al. Among authors: varro a. Gastroenterology. 2006 Apr;130(4):1169-80. doi: 10.1053/j.gastro.2005.12.033. Gastroenterology. 2006. PMID: 16618411
Gastrin receptor pharmacology.
Dockray GJ, Moore A, Varro A, Pritchard DM. Dockray GJ, et al. Among authors: varro a. Curr Gastroenterol Rep. 2012 Dec;14(6):453-9. doi: 10.1007/s11894-012-0293-1. Curr Gastroenterol Rep. 2012. PMID: 22983899
Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.
Moore AR, Boyce M, Steele IA, Campbell F, Varro A, Pritchard DM. Moore AR, et al. Among authors: varro a. PLoS One. 2013 Oct 1;8(10):e76462. doi: 10.1371/journal.pone.0076462. eCollection 2013. PLoS One. 2013. PMID: 24098507 Free PMC article. Clinical Trial.
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
Boyce M, Moore AR, Sagatun L, Parsons BN, Varro A, Campbell F, Fossmark R, Waldum HL, Pritchard DM. Boyce M, et al. Among authors: varro a. Br J Clin Pharmacol. 2017 Mar;83(3):466-475. doi: 10.1111/bcp.13146. Epub 2016 Nov 21. Br J Clin Pharmacol. 2017. PMID: 27704617 Free PMC article. Clinical Trial.
505 results